PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.88−0.31 (-7.40%)
Close on Nov 17, 2026Market cap $268.73MP/E –Yield –
PepGen operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PepGen's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.34M. For fiscal 2025 it was -$81.64M. The highest annual figure on record is -$22.60M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$81.64M | – |
| FY2024 | Dec 31, 2024 | -$82.37M | – |
| FY2023 | Dec 31, 2023 | -$69.00M | – |
| FY2022 | Dec 31, 2022 | -$59.27M | – |
| FY2021 | Dec 31, 2021 | -$22.60M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.81M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.43M | – |
| Q4 FY2025 | Dec 31, 2025 | -$15.85M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.26M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$22.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.48M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.35M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.42M | – |
| Q3 FY2023 | Sep 30, 2023 | -$16.68M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.47M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.42M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.39M | – |
| Q3 FY2022 | Sep 30, 2022 | -$20.97M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.65M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.14M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.83M | – |
See a number that looks wrong?